Ir para o conteúdo principal

Kenvue (NYSE: KVUE) — Perfil da empresa, notícias e dados financeiros

Logo de Kenvue
KVUE Kenvue
Kenvue primary media
Perfil da empresa

Kenvue

Kenvue is a consumer health company operating across self-care, skin health and beauty, and essential health segments. Headquartered in Skillman, New Jersey, the company manufactures and distributes personal care products, over-the-counter medicines, oral care treatments, and dermatologist-tested skincare solutions. Its brand portfolio includes Tylenol, Motrin, Zyrtec, Benadryl, Neutrogena, Aveeno, Listerine, Band-Aid, and Johnson's. Formed through a corporate separation from Johnson & Johnson, the enterprise delivers everyday health products to consumers across North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America, supported by dedicated research facilities and global supply networks.

Resumo

Public USParticipação acionária
2022Ano de fundação
~22,000Funcionários
Summit, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
United States
Japan

Produtos e/ou serviços de Kenvue

  • Self Care & Pain Relief: Over-the-counter analgesics, fever reducers, and anti-inflammatory medications, primarily anchored by Tylenol and Motrin. Products include fixed-dose combinations such as acetaminophen and naproxen sodium formulations distributed globally through retail and pharmacy channels.
  • Allergy & Respiratory Care: Over-the-counter antihistamines and allergy management products led by Zyrtec and Benadryl brands. Operations encompass oral tablets, liquid suspensions, and drug-free nasal mist allergen barrier sprays supplied across North American, European, and Asia-Pacific markets.
  • Skin Health & Beauty: Dermatologist-recommended skin care, hair care, and topical treatments under brands including Neutrogena, Aveeno, OGX, and Rogaine. Offerings focus on moisturizing gels, hydro-boost hydrating serums, anti-aging creams, and topical minoxidil hair regrowth formulations.
  • Oral Care Solutions: Antiseptic mouthwashes and oral rinse product lines marketed globally under the Listerine brand. Operations include alcohol-based and extra-mild antiseptic mouthwash formulations designed to reduce plaque, prevent gingivitis, and treat oral health conditions.
  • Essential & First Aid Health: First aid supplies, wound treatment products, and specialty topicals sold under Band-Aid, Neosporin, and Polysporin brands. Products include adhesive bandages, antibiotic ointments, and healing dressings distributed to retail consumers and healthcare channels.
  • Pediatric & Baby Care: Specialized infant and child personal care products distributed worldwide under Johnson's and Aveeno Baby brands. Offerings comprise tear-free shampoos, baby lotions, eczema relief creams, and gentle cleansers tailored for sensitive infant skin.

equipe executiva do Kenvue

  • Kirk L. PerryCEO & Director
  • Michael P. WondraschChief Technology & Data Officer
  • Matthew OrlandoGeneral Counsel
  • Carlton LawsonGroup President of Europe, Middle East & Africa
  • Heather R. HowlettInterim CFO & Chief Accounting Officer
  • Meredith StevensChief Operations Officer
  • Caroline TillettChief Scientific Officer
  • Sofya TsinisHead of Investor Relations
  • Jonathan HalvorsonChief Digital & Marketing Officer
  • Anil AgarwalHead of Total Rewards

Comunicados recentes

O que a Kenvue (KVUE) comunicou ao mercado, do mais recente para o mais antigo.

  1. 15-12G | Kenvue Inc.

Histórico de dividendos

Dividendos por ação pagos pela Kenvue, por ano fiscal.

Dividendos por ação da Kenvue por ano fiscal
Ano fiscalIntermediárioFinalEspecialTotal
FY2026(até o momento)———$0.8360
FY2025———$0.8260
FY2024———$0.8100
FY2023———$0.4000

Principais indicadores financeiros

Resultados divulgados pela Kenvue, em USD.

Receita e lucro anuais da Kenvue
Fim do ano fiscalReceitaResultado operacionalLucro líquido
15,1 bi2,7 bi1,5 bi
15,5 bi1,8 bi1 bi
15,4 bi2,5 bi1,7 bi
15 bi2,7 bi2,1 bi